PD Dr. Marlen Haderlein



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer (2022) Beck M, Semrau S, Haderlein M, Gostian AO, Hartwich J, Müller SK, Kallies A, et al. Journal article Is elective irradiation of lymph node levels IV and Vb necessary in nasopharyngeal carcinoma? (2022) Semrau S, Haderlein M Journal article, Editorial Extramedullary plasmacytoma: Tumor occurrence and therapeutic concepts-A follow-up (2022) Holler A, Cicha I, Eckstein M, Haderlein M, Poettler M, Rappl A, Iro H, Alexiou C Journal article, Review article Radio(chemo)therapy in anaplastic thyroid cancer—high locoregional but low distant control rates—a monocentric analysis of a tertiary referral center (2022) Schmied M, Lettmaier S, Semrau S, Traxdorf M, Mantsopoulos K, Müller-Hübner SKU, Iro H, et al. Journal article Deep Learning-based Auto-contouring of Lymph Node Levels in Head and Neck Area (2022) Weissmann T, Huang Y, Sommer P, Roesch J, Mansoorian S, Ayala H, Fischer S, et al. Conference contribution Pilot Project for App-based Patient Connection in outpatient Tumor Therapy (2022) Hecht M, Goldbrunner L, Kaul F, Winkler S, Ploner N, Lettmaier S, Haderlein M, et al. Conference contribution In the Case of Radiochemotherapy of advanced Rectal Cancer, there is only slight gender-related Differences, none in terms of Radiation Sensitivity! (2022) Schuster B, Hecht M, Schmidt M, Haderlein M, Jost T, Geinitz H, Fietkau R, Distel L Conference contribution Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer (2022) Müller SK, Haderlein M, Lettmaier S, Agaimy A, Haller F, Hecht M, Fietkau R, et al. Journal article, Review article The Prognostic Value of FoxP3+Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+Cytotoxic T Cell Density (2022) Schnellhardt S, Hirneth J, Büttner-Herold M, Daniel C, Haderlein M, Hartmann A, Fietkau R, Distel L Journal article Influence of gender on radiosensitivity during radiochemotherapy of advanced rectal cancer (2022) Schuster B, Hecht M, Schmidt M, Haderlein M, Jost T, Büttner-Herold M, Weber K, et al. Journal article